Walgreens Boots Alliance
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 139.5b | 132.5b | 132.7b | 139.1b | 145.6b | 147.5b | 150.0b |
% growth | 16 % | (5 %) | - | 5 % | 5 % | 1 % | 2 % |
EBITDA | 3.3b | 5.5b | 6.4b | (2.6b) | 4.4b | 4.0b | 4.5b |
% EBITDA margin | 2 % | 4 % | 5 % | (2 %) | 3 % | 3 % | 3 % |
Profit | 456m | 2.5b | 4.3b | (3.1b) | (6.9b) | 637m | 986m |
% profit margin | - | 2 % | 3 % | (2 %) | (5 %) | - | 1 % |
EV / revenue | 0.3x | 0.4x | 0.3x | 0.2x | 0.1x | 0.1x | 0.1x |
EV / EBITDA | 14.7x | 9.5x | 6.2x | -11.7x | 3.5x | 3.8x | 3.1x |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
* | N/A | $750m | Post IPO Debt |
Total Funding | - |
Recent News about Walgreens Boots Alliance
EditWalgreens Boots Alliance (WBA) is a prominent global player in the retail pharmacy sector. The company's primary mission is to enhance lives by improving health, which it achieves through a comprehensive range of healthcare services and products. WBA operates in the retail pharmacy market, serving a diverse clientele that includes everyday consumers, patients, and healthcare providers.
WBA's business model revolves around its extensive network of retail pharmacies, which are strategically located to maximize accessibility and convenience for customers. The company generates revenue through the sale of prescription medications, over-the-counter drugs, health and wellness products, and beauty items. Additionally, WBA offers various health services, such as vaccinations, health screenings, and consultations, which contribute to its income.
The company has also made significant investments in primary care, as evidenced by its $5.2 billion investment in VillageMD. This move aims to deliver value-based primary care, which focuses on providing high-quality care while controlling costs, to communities across the United States. This strategy aligns with WBA's consumer-centric approach, which is designed to drive long-term growth by meeting the evolving needs of its customers.
WBA is committed to diversity, equity, and inclusion, as highlighted in its latest reports. The company also places a strong emphasis on mental health resources, expanding pharmacist training to better address these needs. Leadership appointments, such as Tiffany Kanaga as Vice President of Global Investor Relations, reflect WBA's focus on strengthening its investor relations and overall corporate strategy.
In summary, Walgreens Boots Alliance is a global leader in retail pharmacy, dedicated to improving health and well-being through a wide range of products and services. The company's strategic investments and consumer-centric approach position it for sustained growth in the healthcare market.
Keywords: retail pharmacy, healthcare, primary care, VillageMD, consumer-centric, diversity, equity, inclusion, mental health, investor relations.